AEGiS-IFRC: Support urged for Global Fund to Fight AIDS, TB and Malaria IFRCImportant note: Information in this article was accurate in 2003. The state of the art may have changed since the publication date.
Click here to return to IFRC main menu
DonateNow


Support urged for Global Fund to Fight AIDS, TB and Malaria

International Federation of Red Cross and Red Cresent Societies - 19 March 2003


The leaders of the world's richest nations were today asked not to betray the hopes raised among the world's poor by the establishment of the Global Fund to Fight AIDS, TB and Malaria (GFATM), diseases which kill six million people each year.

Non-governmental organizations from the US and Europe today publicly launched a campaign, "Fund the Fund," on the opening day of the World Health Assembly in Geneva with the goal of ensuring immediate and long-term funding for the Global Fund.

"It is absolutely essential during the forthcoming G8 summit at Evian that there is a commitment to meet the financing needs of US$1.4 billion for this year and that, for the future, these states agree on an equitable funding mechanism based on gross national product," said Dr. Helene Rossert, who represents NGOs from developed countries on the board of GFATM.

She reviewed the effectiveness of the Global Fund and pointed out that thanks to the initial pledges, funding was now in place to provide anti-tuberculosis treatment to two million people, anti-malaria protection to 30 million African families, medical treatment for 500,000 people living with AIDS and support to 500,000 children orphaned by AIDS. Dr. Rossert said that given the commitments made by governments at the UN special session on HIV/AIDS, held in June 2001, delegates to the World Health Assembly have an obligation to explain the failure to scale up the global response to the HIV/AIDS pandemic in particular.

Her colleague, Dr. Massimo Barra, also spoke to the media today in Geneva. "The situation is now reaching a crisis. Not only are we concerned about the Global Fund's ability to fund new scientifically-approved programmes, we are now faced with the possibility that we will not be able to support approved programmes beyond two years. This is outrageous when we are talking about providing people with life-saving drug therapy for AIDS and tuberculosis," said Dr. Barra of the International Federation of Red Cross and Red Crescent Societies and a NGO representative on the board of GFATM.

"The World Health Assembly will have been a failure if it does not ensure real and practical progress on the delivery of affordable treatments for opportunistic infections and anti-viral medication to the vast majority of people who currently have no access to treatment. This means building health systems and supportive community level networks of volunteers," he added.
030319
IF030301


Copyright © 2003 - International Federation of Red Cross and Red Crescent Societies. Reproduction of this article (other than one copy for personal reference) must be cleared through the IFRC Contact.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.

Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .